According to a new study, GLP-1s may be potentially effective in reducing chronic inflammation.
Sai Balasubramanian is a Contributor at Forbes. He focuses on the intersections of healthcare, digital innovation, and technology, exploring themes such as healthcare administration, patient care, and public health. His insights and expertise have been featured in Forbes, highlighting his commitment to advancing discussions in medicine and healthcare.

















